Seefried, L.
Smyth, M.
Keen, R.
Harvengt, P.
Funding for this research was provided by:
Kyowa Kirin International (NA)
Article History
Received: 3 March 2020
Accepted: 8 July 2020
First Online: 24 July 2020
Compliance with ethical standards
: As this was secondary research, no ethics approval or patient consent was required.
: Lothar Seefried.
: P. Harvengt is a member of RVRH-XLH (a member of the International XLH Alliance), which has received funding from Kyowa Kirin for the organization of educational events, and has provided unpaid consulting services to Kyowa Kirin. P. Harvengt is employed by GSK. This publication was prepared by P. Harvengt in his personal capacity. M. Smyth is a former employee of Kyowa Kirin. R. Keen has received honorarium and consultancy fees from Kyowa Kirin. L. Seefried has received honoraria for lectures and advice from Kyowa Kirin.